Name: UMIN ID:
Unique ID issued by UMIN | UMIN000007781 |
---|---|
Receipt number | R000009099 |
Scientific Title | Multi-center clinical study to investigate the ratio of patients who have achieved Complete Molecular Response (CMR) with nilotinib treatment, among patients with chronic myelogenous leukemia in chronic phase who achieved Major Molecular Response (MMR) with imatinib treatment. |
Date of disclosure of the study information | 2012/04/17 |
Last modified on | 2016/01/05 17:27:04 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/04/17 16:35:36 | ||
2 | Update | 2016/01/05 17:17:36 | Email Last name of contact person Last name of contact person Organization Organization Division name Division name Address Address Name of person sending information Name of person sending information |
|
3 | Update | 2016/01/05 17:22:15 | Recruitment status Last follow-up date Date trial data considered complete |
|
4 | Update | 2016/01/05 17:27:04 | TEL |